A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy: The “SMART” Approach for Resectable Malignant Pleural Mesothelioma

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Thoracic Oncology

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/JTO.0000000000000078PMID 24445595
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• WHO classification of tumours of the lung, pleura, thymus and heart

  2015cited by this paper
• Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up.

  2014cited by this paper
• A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma.

  2014cited by this paper
• The worldwide pandemic of asbestos-related diseases.

  2013cited by this paper
• Use of the posterior pericardium to cover the bronchial stump after right extrapleural pneumonectomy.

  2013cited by this paper
• Patterns of Failure, Toxicity, and Survival after Extrapleural Pneumonectomy and Hemithoracic Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma

  2013cited by this paper
• The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass.

  2013cited by this paper
• Radiation therapy and immunotherapy: implications for a combined cancer treatment.

  2013cited by this paper
• Optimizing Cancer Treatments to Induce an Acute Immune Response: Radiation Abscopal Effects, PAMPs, and DAMPs

  2012cited by this paper
• Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.

  2012cited by this paper
• Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database

  2012cited by this paper
• The MARS feasibility trial: conclusions not supported by data.

  2011cited by this paper
• Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

  2011influential reference
• Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

  2009cited by this paper
• Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment.

  2009cited by this paper
• Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.

  2009influential reference
• Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma.

  2009cited by this paper
• Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma.

  2008cited by this paper
• The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system.

  2008cited by this paper
• Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.

  2007cited by this paper
• Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma.

  2006cited by this paper
• Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations.

  2005cited by this paper
• Advances in malignant mesothelioma.

  2005cited by this paper
• Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies.

  2004cited by this paper
• Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

  2003cited by this paper
• CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

  2003cited by this paper
• A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

  2001cited by this paper
• Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.

  1998cited by this paper
• Latency periods in asbestos-related mesothelioma of the pleura.

  1997cited by this paper
• A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group.

  1996cited by this paper
• Continuing increase in mesothelioma mortality in Britain.

  1995cited by this paper
• A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.

  1995cited by this paper
• Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.

  1989cited by this paper
• Demographic patterns for mesothelioma in the United States.

  1987cited by this paper
• Malignant mesothelioma of the pleura: clinical aspects and symptomatic treatment.

  1984cited by this paper

• Impact of Neoadjuvant and Adjuvant Pleural Intensity‐Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural Mesothelioma

  2025cites this paper
• Low-dose photodynamic therapy promotes vascular E-selectin expression in chest malignancies, improving immune infiltration and tumor control

  2025cites this paper
• Combined quetiapine and radiation therapy approach to treat mesothelioma-initiating cells and increase survival in a mouse model of mesothelioma

  2025cites this paper
• The Role of Surgery in Pleural Mesothelioma: A Journey through the Evidence, MARS 2 and Beyond

  2025cites this paper
• Malignant Pleural Mesothelioma: From Pathophysiology to Innovative Actionable Targets

  2025cites this paper
• FK228 suppress the growth of human malignant pleural mesothelioma tumor independent to epithelioid or non-epithelioid histology

  2024cites this paper
• Pleural Mesothelioma: Treatable Traits of a Heterogeneous Disease

  2023cites this paper
• New Era for Malignant Pleural Mesothelioma: Updates on Therapeutic Options.

  2022cites this paper
• Blocking the GITR-GITRL pathway to overcome resistance to therapy in sarcomatoid malignant pleural mesothelioma

  2021cites this paper
• Malignant pleural mesothelioma: Experience of the Medical Oncology Department of Hassan II Hospital in Fez, Morocco

  2021cites this paper
• Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2021cites this paper
• Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents

  2021cites this paper
• IRF3 Knockout Results in Partial or Complete Rejection of Murine Mesothelioma

  2021cites this paper
• GOECP/SEOR clinical guidelines on radiotherapy for malignant pleural mesothelioma

  2021cites this paper
• Use of Continuous Positive Airway Pressure (CPAP) to Limit Diaphragm Motion—A Novel Approach for Definitive Radiation Therapy for Inoperable Pleural Mesothelioma: A Pilot Study

  2021cites this paper
• Blocking the GITR-GITRL pathway to overcome resistance to therapy in sarcomatoid malignant pleural mesothelioma

  2021cites this paper
• Mesothelioma

  2021cites this paper
• The Immune Microenvironment of Malignant Pleural Mesothelioma: A Literature Review

  2021cites this paper
• The Impact of Adjuvant Hemithoracic Radiation on Outcomes in Patients With Stage I-III Malignant Pleural Mesothelioma

  2021cites this paper
• Prognostic impact of PD-1 and PD-L1 expression in malignant pleural mesothelioma: an international multicenter study

  2021cites this paper
• Extrapleural Pneumonectomy versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma.

  2021cites this paper
• Surgery and Adjuvant or Neoadjuvant Setting of Radiotherapy: What Is the Role of Radiotherapy in Combination with Lung-Sparing Surgery?

  2021cites this paper
• Triple-modality therapy maximizes antitumor immune responses in a mouse model of mesothelioma

  2021cites this paper
• Landmark Trials in the Surgical Management of Mesothelioma

  2021cites this paper
• Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial.

  2021cites this paper
• A narrative review of current treatment strategies and emerging therapies in malignant pleural mesothelioma

  2021cites this paper
• Commentary: A journey of a thousand miles begins with a single step.

  2020cites this paper
• Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma

  2020cites this paper
• Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future

  2020cites this paper
• ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma

  2020cites this paper
• Extrapleural pneumonectomies for pleural mesothelioma

  2020influential citation
• Malignant pleural mesothelioma: recent developments

  2020cites this paper
• OP-EUJC200156 1..24

  2020cites this paper
• Pneumonectomie

  2020cites this paper
• Controversies in the role of radiotherapy in pleural mesothelioma

  2020influential citation
• The 2019 ERS/ESTS/EACTS/ESTRO Guidelines on the Management of Patients With Malignant Pleural Mesothelioma.

  2020cites this paper
• A liquid biopsy for detecting circulating mesothelial precursor cells: A new biomarker for diagnosis and prognosis in mesothelioma

  2020cites this paper
• The Role of Extrapleural Pneumonectomy in Malignant Pleural Mesothelioma.

  2020cites this paper
• Taken Together: Effective Multimodal Approaches for Malignant Pleural Mesothelioma.

  2020cites this paper
• Foxp3+ Regulatory T Cell Depletion after Nonablative Oligofractionated Irradiation Boosts the Abscopal Effects in Murine Malignant Mesothelioma

  2020cites this paper
• Updates in Staging and Management of Malignant Pleural Mesothelioma.

  2020cites this paper
• Radiation Therapy for Malignant Pleural Mesothelioma.

  2020cites this paper
• ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.

  2020cites this paper
• Low-dose photodynamic therapy promotes a cytotoxic immunological response in a murine model of pleural mesothelioma.

  2020cites this paper
• Postoperative but not intraoperative transfusions are associated with respiratory failure after pneumonectomy.

  2020cites this paper
• Surgery for Mesothelioma After Radiation Therapy (SMART); A Single Institution Experience

  2020cites this paper
• Mesothelioma

  2019influential citation
• Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma.

  2019cites this paper
• Progress of malignant mesothelioma research in basic science: A review of the 14th international conference of the international mesothelioma interest group (iMig2018).

  2019cites this paper
• Extra-pleural pneumonectomy.

  2019cites this paper
• The timing of chemotherapy in the management plan for medically operable early-stage malignant pleural mesothelioma

  2019cites this paper
• Defining the role of adjuvant radiotherapy for malignant pleural mesothelioma: a propensity-matched landmark analysis of the National Cancer Database.

  2019cites this paper
• Commentary: Return to intended radiation therapy-Criteria for resection?

  2019cites this paper
• The Future of Mesothelioma Research: Basic Science Research

  2019cites this paper
• Preliminary results of entire pleural intensity-modulated radiotherapy in a neoadjuvant setting for resectable malignant mesothelioma

  2019influential citation
• Mesothelioma: Scientific clues for prevention, diagnosis, and therapy

  2019cites this paper
• Surgery and Multimodality Treatment in Malignant Pleural Mesothelioma

  2019cites this paper
• Malignant Mesothelioma: Has Anything Changed?

  2019cites this paper
• Commentary: Is glue the key to success in malignant pleural mesothelioma?

  2019cites this paper
• Emerging therapies in malignant pleural mesothelioma.

  2019cites this paper
• Prognostic influence of tumor microenvironment after hypofractionated radiation and surgery for mesothelioma.

  2019cites this paper
• Risk factors and biomarkers for malignant mesothelioma

  2019cites this paper
• Caring for Patients with Mesothelioma: Principles and Guidelines

  2019cites this paper
• Commentary: Picking the winners-Leaning into selection bias.

  2019cites this paper
• Surgery for Malignant Pleural Mesothelioma

  2019cites this paper
• Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation

  2018cites this paper
• 18F-FDG PET/CT in the management of patients with malignant pleural mesothelioma being considered for multimodality therapy: experience of a tertiary referral center.

  2018cites this paper
• Treatment of malignant pleural mesothelioma: lessons learned and quo vadis?

  2018cites this paper
• Chest tumors: current trends of clinical practice

  2018cites this paper
• Combined modality treatment in mesothelioma: a systemic literature review with treatment recommendations.

  2018cites this paper
• Non-ablative hypofractionated hemithoracic radiation-a new standard of care in mesothelioma?

  2018cites this paper
• Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting.

  2018cites this paper
• Intensity modulated radiation therapy after extra‐pleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival

  2018cites this paper
• Malignant Pleural Mesothelioma

  2018cites this paper
• Utilization of Intensity‐Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States

  2018cites this paper
• New Concepts in the Treatment of Malignant Pleural Mesothelioma.

  2018cites this paper
• Pleural mesothelioma: is the surgeon still there?

  2018cites this paper
• Chemo-manipulation of tumor blood vessels by a metal-based anticancer complex enhances antitumor therapy

  2018cites this paper
• Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.

  2018cites this paper
• Scientific Advances and New Frontiers in Mesothelioma Therapeutics.

  2018cites this paper
• Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma

  2018cites this paper
• Value of contrast CT in combination with PET/CT in mesothelioma staging: Optimal protocol for initial assessment

  2017cites this paper
• In Situ Vaccination after Accelerated Hypofractionated Radiation and Surgery in a Mesothelioma Mouse Model

  2017cites this paper
• Surgery Approaches in Mesothelioma

  2017cites this paper
• Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma

  2017cites this paper
• Induction chemotherapy vs post-operative adjuvant therapy for malignant pleural mesothelioma

  2017cites this paper
• The rationale for neoadjuvant radiation therapy in malignant pleural mesothelioma: how smart is SMART?

  2017cites this paper
• Radio-immunotherapy and chemo-immunotherapy as a novel treatment paradigm in malignant pleural mesothelioma.

  2017influential citation
• Radiotherapy for the treatment of malignant pleural mesothelioma.

  2017cites this paper
• Overview of treatment related complications in malignant pleural mesothelioma.

  2017cites this paper
• The role of radical radiotherapy in the management of malignant pleural mesothelioma: A systematic review.

  2017cites this paper
• Stem Cell Factor-Based Identification and Functional Properties of In Vitro-Selected Subpopulations of Malignant Mesothelioma Cells

  2017cites this paper
• Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma

  2016influential citation
• Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma.

  2016cites this paper
• SORORIN and PLK1 as potential therapeutic targets in malignant pleural mesothelioma.

  2016cites this paper
• Hemithoracic radiotherapy for mesothelioma: lack of benefit or lack of statistical power?

  2016cites this paper
• Perspective on malignant pleural mesothelioma diagnosis and treatment.

  2016cites this paper
• Current Treatment of Mesothelioma: Extrapleural Pneumonectomy Versus Pleurectomy/Decortication.

  2016cites this paper
• Current surgical strategies for malignant pleural mesothelioma

  2016cites this paper
• Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment

  2016cites this paper